Liangliang Wu

机构：Wuhan University of Science and Technology

发表论文 43 篇 · 总被引 1362 次 · h-index 18

代表论文

• Epigenetics: Roles and therapeutic implications of non-coding RNA modifications in human cancers (2021 · Molecular Therapy — Nucleic Acids · 被引 87)
• Serum insulin‐like growth factor binding protein 2 levels as biomarker for pancreatic ductal adenocarcinoma‐associated malnutrition and muscle wasting (2021 · Journal of Cachexia Sarcopenia and Muscle · 被引 39)
• CD73 induces gemcitabine resistance in pancreatic ductal adenocarcinoma: A promising target with non-canonical mechanisms (2021 · Cancer Letters · 被引 33)
• The Involvement of Ascorbic Acid in Cancer Treatment (2024 · Molecules · 被引 30)
• <p><em>V</em>Up-Regulation of VCAN Promotes the Proliferation, Invasion and Migration and Serves as a Biomarker in Gastric Cancer</p> (2020 · OncoTargets and Therapy · 被引 29)
• Methylation of SLFN11 promotes gastric cancer growth and increases gastric cancer cell resistance to cisplatin (2019 · Journal of Cancer · 被引 25)